22 July 2019

Allen & Gledhill advised PanAsia Health Limited (“PanAsia Health”), which is indirectly controlled by EQT Mid Market Asia III GP B.V., acting in its capacity as general partner of EQT Mid Market Asia III Limited Partnership (“EQT”), and Nam See Investment (Pte) Ltd. (“Nam See Investment”), the founding family and substantial shareholder of Health Management International Ltd (“HMI”), as transaction counsel, on the S$611 million proposed acquisition of all shares in HMI by way of a scheme of arrangement.

Advising PanAsia Health and EQT were Allen & Gledhill Partners Christopher Koh and Wong Yi Jia.

Advising Nam See Investment were Allen & Gledhill Partners Song Su-Min and Chiam Tao Koon.

More

A&G News 12 December 2025

A&G Asia continues to be recognised for its leading position in the region by Chambers and Partners in its 2026 rankings

Read more

A&G News 8 December 2025

US$400 million initial public offering and listing of UltraGreen.ai Limited

Read more